Showing results (151-160 of 254) with videos related to

Sort By:
Pageof 26
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 30, 2018
Quadrivalent human papillomavirus vaccination in girls and the risk of autoimmune disorders: the Ontario Grade 8 HPV Vaccine Cohort StudyErin Y Liu, Leah M Smith, Anne K Ellis, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|March 16, 2021
COVID-19 vaccine testing & administration guidance for allergists/immunologists from the Canadian Society of Allergy and Clinical Immunology (CSACI)Timothy K Vander Leek, Edmond S Chan, Lori Connors, et al.
International Journal of Environmental Research and Public Health|July 26, 2018
Aeroallergens in Canada: Distribution, Public Health Impacts, and Opportunities for PreventionCecilia Sierra-Heredia, Michelle North, Jeff Brook, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 2, 2022
Anxiety in adults with allergic rhinitis during the coronavirus disease 2019 pandemic: A Canadian perspectiveKayley Xu, Sophia Linton, Adam Sunavsky, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 14, 2023
When Supplemental Formula Is Essential: Overcoming Barriers to Hypoallergenic Formula Access for Patients With Food AllergiesFallon Schultz, Christopher Michael Warren, Mirna Chehade, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 7, 2021
Community Use of Epinephrine for the Treatment of Anaphylaxis: A Review and Meta-AnalysisLaura May Miles, Kayadri Ratnarajah, Sofianne Gabrielli, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|August 8, 2024
Focused allergic rhinitis practice parameter for CanadaAnne K Ellis, Victoria Cook, Paul K Keith, et al.
Frontiers in Immunology|July 26, 2021
Efficacy, Safety and Tolerability of a New 10% Intravenous Immunoglobulin for the Treatment of Primary ImmunodeficienciesElena E Perez, Jacques Hébert, Anne K Ellis, et al.
The Journal of Allergy and Clinical Immunology|June 1, 2011
Distinct immune effector pathways contribute to the full expression of peanut-induced anaphylactic reactions in miceKatherine Arias, Derek K Chu, Kristin Flader, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 13, 2026
Pharmacokinetics and pharmacodynamics following repeat dosing of neffy (epinephrine nasal spray) versus intramuscular injection during induced allergic rhinitisJohn Oppenheimer, Thomas B Casale, Jonathan M Spergel, et al.
Pageof 26